IQVIA Holdings Inc.
$271.36
$2.54 (+0.94%)
$268.80Day Range$273.88
Key Statistics
Market Cap
$44.25B
Shares Outstanding
164.6M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
May 9, 2013
Round Lot
100
Locale
US
Trading Data
Day Open
$273.15
Day High
$273.88
Day Low
$268.80
Volume
842.2K
VWAP
$271.89
Prev Close
$268.82
Transactions
--
Acc. Volume
--
About IQVIA Holdings Inc.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHSIC 873194,000 employees2400 ELLIS ROAD, DURHAM, NC, 27703919-998-2000IPO May 9, 2013US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001478242
- Composite FIGI
- BBG00333FYS2
- Share Class FIGI
- BBG00333FZ54
- Ticker Root
- IQV
- SIC Code
- 8731
About IQVIA Holdings Inc. (IQV) Stock
IQVIA Holdings Inc. (IQV) closed the 2026-09-17 session at $271.36, up 0.94% versus the previous close (+2.54). The stock opened at $273.15 and traded between $268.80 and $273.88 during that session. Session trading volume was 842K shares. The volume-weighted average price (VWAP) is $271.89.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
IQVIA Holdings Inc. has a market capitalization of $44.25 billion. The company operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry classification. IQV is listed on the XNYS exchange. The company employs approximately 94,000 people. IQVIA Holdings Inc. is headquartered in DURHAM, NC. The recorded listing date is 2013-05-09.
On this page you can find market IQV stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector.